Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week r
Identificadores
Identificadores
Fecha de publicación
2014Título de revista
LANCET INFECTIOUS DISEASES
Tipo de contenido
Artigo